FDA Will Customize Foreign Facility Inspections To Improve Efficiency
This article was originally published in The Gray Sheet
Executive Summary
FDA inspectors will take a more customized approach to auditing foreign device manufacturing facilities in 2006 to improve the efficiency of costly overseas trips, device center Office of Compliance Director Tim Ulatowski suggests
You may also be interested in...
House Panel Probes FDA Inspections Of Overseas Device Facilities
With Congress increasingly focused on improving safety checks for products imported into the United States, FDA oversight of foreign device manufacturing facilities is getting pulled into the mix
House Panel Probes FDA Inspections Of Overseas Device Facilities
With Congress increasingly focused on improving safety checks for products imported into the United States, FDA oversight of foreign device manufacturing facilities is getting pulled into the mix
CDRH Compliance Office Seeks Inroads With FDA Office Of Regulatory Affairs
The top near-term contribution of the Office of Compliance to CDRH's postmarket reform effort will be trying to improve its working relationship with FDA's Office of Regulatory Affairs